MX2022012059A - Aumento de la produccion de vectores de genetransferencia a base de adenovirus. - Google Patents

Aumento de la produccion de vectores de genetransferencia a base de adenovirus.

Info

Publication number
MX2022012059A
MX2022012059A MX2022012059A MX2022012059A MX2022012059A MX 2022012059 A MX2022012059 A MX 2022012059A MX 2022012059 A MX2022012059 A MX 2022012059A MX 2022012059 A MX2022012059 A MX 2022012059A MX 2022012059 A MX2022012059 A MX 2022012059A
Authority
MX
Mexico
Prior art keywords
production
adenovirus
genes
adenoviral
enhancement
Prior art date
Application number
MX2022012059A
Other languages
English (en)
Inventor
Uwe D Staerz
Original Assignee
Greffex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greffex Inc filed Critical Greffex Inc
Publication of MX2022012059A publication Critical patent/MX2022012059A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/50—Biochemical production, i.e. in a transformed host cell
    • C12N2330/51—Specially adapted vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10041—Use of virus, viral particle or viral elements as a vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10051—Methods of production or purification of viral material
    • C12N2710/10052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material
    • C12N2710/10352—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/14011—Filoviridae
    • C12N2760/14111—Ebolavirus, e.g. Zaire ebolavirus
    • C12N2760/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

En un aspecto, las modalidades descritas en la presente se relacionan a la producción de vectores de suministro de gen a base de adenovirus completamente suprimido, empaquetados sin el uso de un virus ayudante adenoviral, y más particularmente en su uso en la transferencia de genes y la expresión de proteínas, desarrollo de vacuna e ingeniería celular. En otro aspecto, se describe la producción de vectores adenovirales suprimidos de todos los genes adenovirales que llevan genes de interés con actividades perjudiciales o tóxicas a las células eucariotas.
MX2022012059A 2020-03-30 2021-03-29 Aumento de la produccion de vectores de genetransferencia a base de adenovirus. MX2022012059A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063001758P 2020-03-30 2020-03-30
PCT/US2021/024578 WO2021202333A1 (en) 2020-03-30 2021-03-29 Enhancement of the production of adenovirus-based genetransfer vectors

Publications (1)

Publication Number Publication Date
MX2022012059A true MX2022012059A (es) 2023-02-14

Family

ID=77928952

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022012059A MX2022012059A (es) 2020-03-30 2021-03-29 Aumento de la produccion de vectores de genetransferencia a base de adenovirus.

Country Status (7)

Country Link
US (1) US20230235354A1 (es)
EP (1) EP4127190A4 (es)
JP (1) JP2023519963A (es)
CN (1) CN115803439A (es)
CA (1) CA3173713A1 (es)
MX (1) MX2022012059A (es)
WO (1) WO2021202333A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7232899B2 (en) * 1996-09-25 2007-06-19 The Scripps Research Institute Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
FR2882062B1 (fr) * 2005-02-14 2007-06-15 Commissariat Energie Atomique Vecteurs d'expression stable et de longue duree de sirna et leurs applications
US8871515B2 (en) * 2008-09-17 2014-10-28 Isogenis, Inc. Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
WO2013075008A1 (en) * 2011-11-16 2013-05-23 University Of Florida Research Foundation Inc. Aav dual vector systems for gene therapy
WO2018165929A1 (zh) * 2017-03-15 2018-09-20 深圳市博奥康生物科技有限公司 一种双miRNA抑制表达载体及其构建方法和应用

Also Published As

Publication number Publication date
JP2023519963A (ja) 2023-05-15
CA3173713A1 (en) 2021-10-07
US20230235354A1 (en) 2023-07-27
EP4127190A4 (en) 2024-05-29
WO2021202333A1 (en) 2021-10-07
CN115803439A (zh) 2023-03-14
EP4127190A1 (en) 2023-02-08

Similar Documents

Publication Publication Date Title
Suh et al. Yeast flavin-containing monooxygenase generates oxidizing equivalents that control protein folding in the endoplasmic reticulum
WO2020097372A8 (en) Use of adeno-associated viral vectors to correct gene defects/ express proteins in hair cells and supporting cells in the inner ear
BR112017000696A2 (pt) Citomegalovírus humano recombinante (hcmv), sua composição imunogênica, seu uso, polinucleotídeo isolado, célula isolada e método de produção de hcmv com deficiênciade pp71
MX2019008755A (es) Variantes de hsd17b13 y usos de las mismas.
CA3057899A1 (en) Diaphragm-specific nucleic acid regulatory elements and methods and use thereof
CL2019003842A1 (es) Vectores virales recombinantes con tropismo modificado y usos de estos para la introducción dirigida de material genético a células humanas.
WO2010033722A3 (en) Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
PH12021550761A1 (en) Methods and compositions for ocular cell therapy
MX2021009554A (es) Produccion de virus en cultivos celulares.
BR112021026832A2 (pt) Vetores ad35 recombinantes e aprimoramentos da terapia gênica relacionada
NZ743682A (en) Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes
MX2020005663A (es) Terapia genica para mucopolisacaridosis iii a.
MX2022012059A (es) Aumento de la produccion de vectores de genetransferencia a base de adenovirus.
MX2022004311A (es) Estirpes celulares de mamiferos con deficiencia de lipasa/esterasa modificadas geneticamente de manera recombinante.
DK0843731T3 (da) Adenovirusvektorer til genterapi
MX2022005670A (es) Composiciones y metodos para recombinacion de alta eficiencia de moleculas de arn.
ATE473763T1 (de) Replizierende adenovirus-vektoren
Yuxiang et al. Current advance in engineered living materials
ATE338826T1 (de) Rekombinante virale vektoren zur tetracyclinregulierbaren genexpression
MX2023007376A (es) Parapoxvirus modificado que tiene inmunogenicidad incrementada.
WO2022011356A3 (en) Aav vector delivery systems
MX2023002080A (es) Vector de poxviridae recombinante que expresa moleculas coestimuladoras.
MX2022002060A (es) Un vector viral híbrido procariota-eucariota para el suministro de grandes cargas de genes y proteínas a células humanas.
MX2022012060A (es) Vectores adenovirales de ave deficientes en la replicacion, sus dise?os y usos.
TR202007437A2 (tr) PEtOx-PCL Elipsoitlerinin Non-Viral Vektör Olarak Kullanımı